Hum 4956 Arts for Health Peace and Community Engagement in Northern Ireland

Abstract

Health systems accept improved their abilities to identify, diagnose, treat and, increasingly, achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a higher burden of multimorbidity and poorer health-related quality of life are reported by many PLHIV in comparison to people without HIV. Stigma and bigotry further exacerbate these poor outcomes. A global multidisciplinary group of HIV experts developed a consensus statement identifying primal issues that health systems must address in order to move beyond the HIV field'southward longtime accent on viral suppression to instead evangelize integrated, person-centered healthcare for PLHIV throughout their lives.

Introduction

Following the introduction of highly effective antiretroviral therapy (ART) in 1996, the global scale-up of Art resulted in substantial declines in AIDS-related morbidity and mortality. By the end of 2019, 67% of the world's estimated 38 million people living with HIV (PLHIV) had initiated ART, with 59% achieving viral suppression¹. The life expectancy for PLHIV who are diagnosed early and are able to take continuous ART now approaches that of the full general population². Withal, despite viral suppression, PLHIV oftentimes report poor well-being and health-related quality of life (HRQoL)^{3,4,five,6,vii}.

Factors negatively affecting the HRQoL of PLHIV include multimorbidity, drug and alcohol dependence, poverty, social isolation, difficulties disclosing HIV status, and persecution due to discriminatory laws and attitudes^{vii,8,9,x,xi,12,13,14}. HIV-related stigma and bigotry negatively touch the HRQoL of PLHIV through multiple pathways, including social rejection, low cocky-esteem, and barriers to accessing health and back up services^{15,sixteen,17}. These problems phone call for a broad wellness system response to the health-related needs of PLHIV. This includes the provision of integrated services for the prevention and management of communicable and not-infectious disease, forth with psychosocial and other back up to address mutual psychological, social, and admission challenges. Budgeted the healthcare of PLHIV holistically, with determination-making driven by the person'south priorities rather than by a pathogen-specific prototype, has the potential to yield better overall health outcomes¹⁸. Comprehensive, multidisciplinary healthcare for PLHIV requires an integrated, person-centered approach. This is likely to enhance HRQoL and contribute to improvements in population-level health beyond all domains, including infectious and noncommunicable diseases, mental health, and sexual and reproductive health.

Achieving consistent, long-term virological suppression has go a key marker of successful HIV intendance^xix,twenty. Whilst access to constructive ART for all remains essential, it should exist seen equally ane aspect of a more multifaceted definition of success. The key goal should be integrated, person-centered healthcare that promotes the importance of HRQoL, recognizing the right of all people to enjoy "the highest attainable standard of concrete and mental health"²¹. The Earth Health Organization (WHO) Global wellness sector strategy on HIV 2016–2021 briefly addresses the non-HIV-specific chronic care needs of PLHIV although without mention of HRQoL²². UNAIDS has included a general health target for PLHIV in its strategic guidance for the first time in 2021. It calls for 90% of PLHIV to "have access to integrated or linked services for HIV handling and cardiovascular diseases, cervical cancer, mental wellness, diabetes diagnosis and treatment, educational activity on healthy lifestyle counseling, smoking cessation communication and physical practice"²³. Recently, national and regional initiatives have promoted a more person-centered HIV care agenda^24,25. This reflects the global move towards person-centered care for illness in general. A torso of testify, including studies of PLHIV, exists to underpin the concept and practise, which is largely, merely not exclusively, from high-income coutries²⁶. Person-centered healthcare must value the social networks of patients, promote quality of life, and reform structurally to better patients' experience interacting with the healthcare system, including respect for and protection of homo rights. However, at that place is not yet a common understanding of what the cadre values and practices of person-centered, holistic treat PLHIV should encompass, or how aspects of this upshot may exist context-specific.

Equally a first stride in achieving a common understanding, a multidisciplinary skilful panel was convened to engage in a Delphi process to develop a consensus statement on the role of health systems in advancing the long-term well-being of PLHIV from a patient-centered perspective. The overarching purpose of the consensus statement is to guide global, regional, national, and subnational stakeholders in improving wellness organization responses to achieve the best possible long-term health outcomes for PLHIV, including HRQoL outcomes. This article reports on the consensus evolution procedure and the agreed-upon consensus points.

Methodology

We employed a standard six-stage Delphi process^27,28, including the definition of the problem and identification of experts (Stages 1 and 2, concurrently), three survey rounds (Stages iii–5), and deportment based on the findings (i.eastward., endorsement of consensus statements and recommendations; Stage 6)²⁹. (Further details of the methodology for this Delphi study are presented in the Supplementary Information.) The research team (J.5.L., Grand.Due south.) established an expert console comprised of 44 individuals with expertise in the long-term health needs of PLHIV. The expert panel encompassed diverse disciplinary and geographical perspectives, besides every bit wide-ranging lived experiences (Tabular array 1, Table 2). Xi good panel members, including two people living openly with HIV, served equally members of a steering committee that was tasked with providing conceptual guidance for this project (J.A., R.B.Fifty.*, G.B., G.C., N.D.*, Yard.J.F., R.H., A.M.*, J.V.Fifty.*, C.S., K.Southward.) (project co-chairs denoted past *). Three teams of steering committee members led scoping reviews of the literature on multimorbidity (Thou.B., A.K.), HRQoL (M.J.F., R.H.), and stigma and bigotry (J.A., K.C.) in social club to identify priority issues to consider for the consensus argument. Specifically, the main findings from the respective reviews guided decision-making regarding potential consensus points. In detail, issues thought to exist hard to accost or inadequately addressed (e.grand., measurement of health-related quality of life, approaches to addressing stigma) were accounted important by the steering commission and expert panel members alike to include in the consensus process.

Tabular array 1 Expert panel members.

Full size table

Table 2 Expert console demographic composition and level of date.

Full size table

The enquiry team drew on health system-related issues identified in the scoping reviews to develop an initial set of 29 proposed consensus points with input from steering committee members. Expert panel members were then asked to indicate agreement or disagreement with consensus points in iii survey rounds using the Delphi methodology, with further input collected via qualitative comments on each draft betoken. In addition, their views were sought on selected topics at an online meeting between the second and third survey rounds.

Results

Overall, understanding consistently increased for the consensus points beyond survey rounds, which is likely indicative of the incorporation of modifications based on the open up-ended comments into the final 2 rounds. In the third survey round, expert panel members reported unanimous understanding with 22 of the 31 items, and greater than 90% agreement with the remaining nine items (Tabular array three). In only 3 of the final 31 points did we observe a somewhat different design: signal 2.iv had a slight shift from 'Agree' to 'Somewhat concur'; point four.i had slight shifts from 'Agree' and 'Disagree' to 'Somewhat concur'; and point i.3 had a slight shift from 'Agree' to 'Disagree.' For these 3 points, nonetheless, the aggregate ratings were notwithstanding strongly in understanding. (See the Supplementary Data for an explanation of the consensus grading rubric employed.)

Table three Consensus points on the role of health systems in advancing the long-term well-beingness of people living with HIV (PLHIV).

Full size table

Key terms used in the consensus statement are described in Box 1. HIV organizations globally were invited to endorse the final consensus statement (Box ii).

Summary of bear witness

Multimorbidity

PLHIV worldwide have a greater burden of multimorbidity than people without HIV and this burden increases with age^iii,30,31,32. Mutual comorbidities include hepatitis B, hepatitis C, tuberculosis, and crumbling-associated noncommunicable diseases such every bit cardiovascular disease, chronic kidney disease, osteoporosis, and cervical, anal, and other cancers^{33,34,35,36,37}. Even with admission to effective Art, PLHIV are more likely than people without HIV to feel low and other mental health disorders, including substance use disorders¹⁶. Irrespective of whether these conditions precede the HIV infection, which may affect prevention and treatment, multimorbidity in PLHIV is associated with college levels of hospitalization³⁸, higher healthcare costs³⁹, higher levels of polypharmacy⁴⁰, and lower HRQoL^7,13.

Factors contributing to the college multimorbidity burden in PLHIV include belatedly diagnosis of HIV, Art toxicities, and long-term furnishings of HIV on the immune arrangement^41,42. Even amidst PLHIV who accomplish long-term viral suppression, chronic allowed activation may contribute to the onset of aging-related comorbidities^43,44. Determinants of health, including social determinants such as poverty, stigma, and bigotry, also as ecology factors such as criminalization and incarceration put some PLHIV at increased chance of developing comorbidities and having poorer comorbidity outcomes^13,45,46,47. Health-related behaviors such as smoking and dependent drug or alcohol use further add to the multimorbidity brunt⁴⁸. Difficulty in disclosing a positive HIV status, as well as experiences of stigma and discrimination deeply affect the mental health of PLHIV and introduce barriers to appointment in intendance, hence increasing the risk of poor health outcomes^15,49.

Disease-specific approaches to the provision of health services for PLHIV are likely to be inefficient, particularly because it is mutual for multiple comorbidities to share the same take chances factors, resulting in syndemics⁵⁰. Integrated healthcare models tailored to reflect the multimorbidity-related needs of PLHIV in unlike geographical settings have the potential to deliver better health outcomes, if implemented equitably⁵¹, and can do then price-finer⁵². By addressing the prevention, screening, and direction of comorbidities in a person-centered manner, guided by the needs of individual patients, health systems can also respond flexibly to the multidimensional process of aging with HIV, taking into business relationship both chronic and episodic health-related needs⁵³. The priorities of PLHIV may differ from those of service providers. For case, PLHIV may be more concerned than providers nearly bug such equally pain and sleep disturbance⁵⁴. Addressing concerns identified by PLHIV will be of import for effective treatment and symptom direction.

A new prototype is needed for addressing multimorbidity in PLHIV. The conceptualization of frailty in geriatric healthcare suggests a framework for identifying PLHIV who are at higher run a risk of poor wellness outcomes⁵⁵. WHO'south conceptualization of healthy aging as a process that is influenced by both intrinsic chapters and the environment may also provide insights, along with the related concept of functional power, which emphasizes people's ability to do what is of import to them at different stages of their lives^55,56. Further research is needed to determine how these approaches can inform the clinical care of PLHIV.

Health-related quality of life

Health is defined by WHO as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity"⁵⁷, while international police recognizes the human right of all persons to "enjoyment of the highest attainable standard of physical and mental health" and requires States to take measures to progressively realize this right over time⁵⁸. HRQoL is increasingly acknowledged as an of import aspect of wellness. Information technology is ordinarily assessed by patient-reported result measures (PROMs), which reflect people's subjective perceptions of their wellness-related experiences⁵⁹. Validated PROMs can be used to systematically quantify people's HRQoL, allowing for observations about how HRQoL varies amongst individuals, across groups, and over fourth dimension. The comprehensive multidimensional nature of PROMs that measure HRQoL makes them a useful tool for determining how well people are responding to the challenges associated with complex chronic wellness conditions. Incorporating HRQoL monitoring into clinical and community services for PLHIV can provide a person-centered perspective on the effectiveness of interventions, inform wellness-related decision-making, and place PLHIV who would benefit from clinical and community services to address modifiable factors that negatively bear on HRQoL.

The relevance of HRQoL as a mensurate of well-beingness amongst PLHIV is well-established. PLHIV have reported poorer HRQoL when compared to members of the general population, and besides poorer HRQoL than people with other chronic health conditions^3,4,v. Poorer HRQoL scores are closely correlated with worse clinical wellness measures such as low CD4 T-prison cell count and the occurrence of AIDS-defining events^60,61,62,63. While comorbidities, disability, and pain impair HRQoL^7,64,65,66, successful HIV treatment has a positive touch on^67,68. Physical and mental dimensions of HRQoL scores predict viral rebound and all-cause hospitalization⁶⁹. Better scores on the physical dimension of HRQoL predict survival among PLHIV receiving ART, too as emergency department utilization and hospital belch rates^70,71. Enhancing HRQoL has the potential to improve clinical outcomes, adherence, and retention in care^7,60.

PLHIV written report a number of components of HRQoL that are important to them. These include physical (e.g., pain and gastrointestinal problems), cognitive (e.thou., memory and sleep), psychological (e.g., anxiety and depression), social (e.thousand., isolation and intimacy), functional (due east.g., independence and ability to perform everyday activities), welfare (e.g., finances and fears regarding clearing condition), spiritual well-being (e.g., achieving a sense of peace), and information (e.k., about long-term outcomes about their condition) components^72,73,74. However, issues that are important to PLHIV, especially non-physical issues, peradventure missed past those providing routine clinical care due to existing service delivery structures and a lack of preparation almost and awareness of these problems⁷⁵. A healthcare approach that focuses solely or primarily on laboratory results may lead PLHIV to feel that the physical and psychosocial concerns that matter to them are not every bit important to their healthcare providers⁷⁶. Therefore, validated PROMs used to mensurate HRQoL should reverberate the symptoms and concerns reported past PLHIV and should be culturally appropriate, including for marginalized groups. Several internationally validated instruments, generic and HIV-specific, are currently used to measure out HRQoL in PLHIV for general population comparisons, medico-economical assessments, and specific inquiry and clinical purposes (e.g., SF-12v2, MOS-HIV, PROQOL-HIV, WHOQOL-bref)⁵⁹. Equally both internalized and enacted stigma negatively impact HRQoL^77,78, some validated instruments, such every bit PROQOL-HIV⁷⁹, have included a sub-scale measuring stigma as a component of HRQoL.

Potential benefits of using PROMs in routine HIV intendance have been readily identified by PLHIV and their service providers: achieving a person-centered approach, empowering individuals to raise concerns, feeling that all concerns are heard and taken seriously, facilitating discussion of sensitive issues, increasing date with services and handling adherence, and identifying who is benefiting or not benefiting from care and support strategies⁴⁷.

HIV-related stigma and discrimination

PLHIV may experience multiple forms of stigma and discrimination at various levels (e.g., policy and law, wellness organization, and interpersonal) and in dissimilar settings (e.yard., health sector, teaching, workplace, the justice system, families and communities, and emergency and humanitarian settings)⁸⁰. Such experiences have direct social and wellness consequences (e.g., depression, anxiety, substance use, impaired quality of life, social exclusion, internalized stigma)¹⁶. They likewise adversely affect decisions regarding prevention behaviors, date in intendance, and uptake of social services^81,82,83,84.

Discriminatory laws that criminalize or otherwise punish fundamental populations, or that prohibit or impede the delivery of specific wellness services (e.yard., affordable medications, harm reduction services, drug dependence treatment, and sexual and reproductive healthcare), or that fail to respect and protect human rights such as privacy or autonomy in medical decisionmaking, found major barriers to the successful implementation of models for comprehensive intendance for PLHIV⁸⁵. Legal and policy frameworks also tin can harm the textile well-being of PLHIV when social security programs do not adequately support those experiencing disability related to HIV or comorbidities, or when HIV or comorbidity services are not reimbursed, resulting in catastrophic wellness expenditure⁸⁶.

These examples underscore the part of HIV-related stigma every bit a major driver of wellness inequities⁸⁷. The stigma associated with real or perceived HIV condition, including within healthcare settings, also intersects with other forms of stigma and discrimination related to social identities or characteristics, e.g., race, ethnicity, sexual orientation, gender identity, age, disability, poverty, migrant status, sex activity work, drug utilize, and prior or current incarceration^xv,88. This intersectional stigma can adversely affect physical and mental wellness outcomes¹⁵. Layered stigma intensifies the intertwined stigma-discrimination-care relationship, which may lead to delayed, sub-optimal, or avoided care^81,82. The overload acquired by suffering intersectional stigmas has adverse furnishings on both mental health and health behaviors. This ways that the health, economic, and social needs of PLHIV suffering structural inequality must be viewed through the prism of intersectionality if there is to be a reduction in the cognitive, social, physical, and moral distancing these groups experience from that of other people⁸⁹.

Examples of stigma and discrimination reported by PLHIV in healthcare settings include excessive infection command precautions taken by providers, longer waiting times, disrespect, negligence, reduced confidentiality, delay or denial of treatment, and poor support services⁹⁰. Two mechanisms human action in synergy: reduced intendance-seeking behaviors for fear of experiencing stigma and bigotry, and the stigmatizing and discriminatory actions of healthcare staff. Secondary stigma, arising from providing care to stigmatized groups, can also touch health providers and modify their attitudes^ninety. PLHIV with multimorbidity may exist treated in services where HIV-related stigma could be compounded by additional stigma associated with specific comorbidities (e.thou., low or liver cancer⁸⁴) or through lack of experience with PLHIV. Specific integrated or shared care models incorporating specialists in HIV and other staff, and the development of HIV-friendly practices, are promising approaches to providing person-centered, continuous care^91,92.

Given the pervasiveness of stigma and discrimination directed at PLHIV in healthcare settings, it is crucial to monitor this experience using validated measures. HRQoL instruments including a stigma dimension (e.g., PROQoL)⁷⁹ may provide an choice for data collection of routine patient-reported outcomes. Some validated instruments, such as the People Living with HIV Stigma Index 2.0⁹³ and the HIV Stigma Scale⁹⁴, which have been validated in various settings around the globe with back up from PLHIV, monitor longitudinal trends of experienced stigma⁵⁹. These could be complemented with measures of stigma expressed past healthcare providers^95,96,97,98.

Interventions to counter HIV-associated stigma should besides be implemented^99,100. Such interventions take been evaluated^{15,101,102,103} and can be categorized as: information-based, structural, biomedical, skill-building, empowerment-based, and contact-centered⁹⁸. Interventions may be patient-focused or provider-focused, and it is possible that optimal impact may be achieved when combinations of interventions are employed. However, further evidence on the effectiveness of such interventions is needed. At a minimum, all types of healthcare settings should provide PLHIV with information nigh their human rights and a channel for reporting behaviors and policies that are discriminatory or otherwise infringe upon rights in this setting.

Discussion

While standing to press for the crucial goal of equitable universal access to ART, health systems must also expand the focus of HIV care. This broader approach will enable PLHIV to feel optimal long-term well-being, consequent with the realization of the human being right to relish the highest attainable standard of physical and mental health. With this goal in heed, the multidisciplinary expert console developed this consensus statement on the role of wellness systems in advancing the long-term well-existence of PLHIV. The process resulted in 31 items with which expert panel members expressed high levels of agreement. The consensus statement reflects the electric current state of knowledge well-nigh health-related challenges for PLHIV in the key domains of multimorbidity, HRQoL, and stigma and discrimination, as well equally addressing psychosocial needs associated with these issues. Proposed measures for improving the long-term health outcomes of PLHIV build on key principles in the fields of HIV and global health, including principles expressed in the Constitution of the World Wellness Organization⁵⁷, the 2030 Calendar for Sustainable Evolution¹⁰⁴, the Un Political Declaration on Universal Health Coverage¹⁰⁵, and the WHO Framework on Integrated, People-Centered Wellness Services¹⁰⁶. This consensus statement and the associated recommendations for activeness accept the potential to ameliorate the well-being of PLHIV throughout their lives.

It has long been recognized that respecting, protecting, and fulfilling human being rights can yield better wellness outcomes for PLHIV⁴⁹, nevertheless human rights are contested in ways that undermine many aspects of the HIV response worldwide. As health systems focus more on the long-term care needs of PLHIV, it is imperative to address the human rights challenges that undermine this effort. Discrimination against PLHIV in healthcare settings is one of many such issues that warrant urgent attention⁸⁰. While some matters are determined past actors outside of health system institutions (e.grand., lawmakers adopting laws that regulate sure aspects of how wellness systems operate and how services are delivered), it is within the power and purview of health system actors (institutions and individuals) to influence many structural factors so as to reduce discrimination and other barriers. Therefore, health systems and the people who piece of work within them must recognize and work to eliminate the multiple forms of structural discrimination that undermine the health of PLHIV. They have an important vantage point as observers of the consequences of such barriers for health and HRQoL and an influential position as advocates, with considerable moral and political persuasion. They also deport responsibility for removing such barriers within healthcare settings, for case by promoting initiatives to hire diverse and inclusive workforces, establishing systems to report and investigate discrimination, and providing wellness services in geographical locations and at times that will facilitate admission for marginalized or vulnerable populations. A pervasive and highly problematic form of structural discrimination is HIV criminalization (i.east., the unjust application of criminal law to people living with HIV based solely on their HIV status), alongside the criminalization and stigmatization of various activities associated with HIV risk¹⁰⁷. Other relevant and pressing human rights problems include privacy and confidentiality, personal autonomy, admission to justice, and meaningful participation in wellness decisionmaking¹⁰⁸.

Meaningful participation can be avant-garde by including PLHIV in the development and enactment of policy and programmatic responses, as chosen for by the widely endorsed Greater Involvement of People Living with HIV Principle¹⁰⁹. PLHIV have unique insight into the factors that positively and negatively affect their well-existence. Their perspectives are essential in the formulation of effective strategies both at the policy and the service delivery levels¹¹⁰. The 2021 United Nations Political Declaration on HIV and AIDS called for the expansion of community-led HIV service delivery to contain at to the lowest degree 30% of testing and handling-related services past 2025¹¹¹. This target is even more important in the context of improving the long-term health-related outcomes of PLHIV. Customs-based health and psychosocial service providers can do more supplement government and individual services; they besides are well-suited to place innovative and price-effective models of care and to appoint marginalized and vulnerable populations^19,110. Efforts to accost the needs of PLHIV in relation to multimorbidity, HRQoL, and stigma and discrimination can be profoundly enhanced through the involvement of communities in setting the research and programmatic agendas, also as in direct service commitment; such activities demand to be sustainably supported and financed.

Evidence suggests that living long-term with HIV tin bring episodic functional concerns¹¹². Continuous cess in routine care is essential for anticipation, detection, and direction of fluctuating concerns. Such care should include HRQoL measures that take a multidimensional approach, reflecting what matters to PLHIV, including concerns such every bit stigma and social function^72,113. For self-reported HRQoL outcomes to inform intendance commitment in a more person-centered manner, wellness systems and service organizations must pay careful attention to language, civilisation, and local and private priorities regarding well-beingness. Information should be collected and used within a meaningful patient-provider human relationship in order to optimize validity and reliability¹¹⁴. This has been achieved even in resource-limited settings with poor literacy and advanced HIV infection¹¹⁵. Locally developed systems in Africa, for example, take enabled patients to self-report using a "hand-scoring" system¹¹⁶. Other systems support community caregivers of people with cancer and HIV in Republic of india and African countries to collect self-reported patient outcomes using mHealth, providing data directly to a provider "dashboard" to inform the allocation of staff resource to those about in need¹¹⁷. A growing body of bear witness indicates that service delivery approaches to HIV care can comprise attending to patient experiences and concerns in high-prevalence, depression-resource areas^85,118.

The practiced panel carried out its work with the understanding that health systems vary substantially beyond, and often within, countries. Patterns of multimorbidity likewise vary greatly across geographical regions. Monitoring progress in the global HIV response requires a set of standardized indicators of health behaviors and comorbidities that contribute substantially to the global multimorbidity burden¹¹⁹. To the extent that resource allow, wellness systems are strongly encouraged to monitor these behaviors and comorbidities and to solicit input from PLHIV on additional national monitoring priorities^ane,120. Although many national health systems are not currently monitoring HRQoL, stigma, or discrimination amidst PLHIV, they should, at a minimum, include indicators from the UNAIDS Global AIDS Strategy 2021–2026, in order to standardize monitoring.

In its Global AIDS Strategy, UNAIDS set ambitious 2025 targets. It established 10 consequence areas that broadly aim to achieve equitable admission to fully-resourced and integrated HIV services for all people living with or at gamble of HIV. Priority actions, which support the targets and result areas, are generally aimed at national governments, though nearly all require back up from non-government stakeholders. While priority actions may vary past geographic region, even in the context of limited resources, our consensus statement offers concrete recommendations regarding multimorbidity, HRQoL, and stigma and discrimination that all wellness systems should aspire to implement. The consensus points and next steps (Box 3) articulate the direction in which healthcare for PLHIV should evolve in all countries, emphasising that a reorientation of health systems will necessarily be incremental. The good console as well recognises that the evidence base of operations underpinning its conclusions is express in some ways simply rapidly growing. Thus the consensus statement should be regarded as an initial articulation of a transformational procedure, to be refined equally stakeholders in regime, civil gild, research, healthcare and the social and legal sectors deepen their agreement of how health systems tin can support PLHIV in achieving optimal well-beingness.

Beyond the three Delphi rounds, three consensus points (two.iv, 4.1, and 4.4) generated lower overall agreement than the others. This was reflected in our determination to keep to evaluate them on a 4-point Likert scale in the third Delphi round instead of the binary agree/disagree measurement used with the other points. The results from that round revealed a continued, relatively lower level of agreement for two of the statements (ii.4 and iv.1) (Tabular array 3). The lack of unanimity here may highlight a lack of consensus among different types of stakeholders in the broader HIV field regarding whether some issues (eastward.chiliad., pain) should exist prioritized in health system efforts to improve health outcomes for PLHIV. It may also reverberate the lack of shared conceptual frameworks for other problems such as stigma and discrimination, punitive laws, and intersectionality, pointing to a possible need to appoint a wider range of stakeholders in dialog about these issues.

Limitations and strengths

The Delphi process involving a virtual adept panel enables the systematic gathering of the commonage noesis and recommendations of leaders in the field while separated by concrete distances^27,121. Still, this process has both limitations and strengths. Typical of the Delphi method, the inquiry team used purposive sampling to recruit potential skillful panel members from existing HIV networks. The initial roster was and then expanded using snowball sampling to include a wider range of experts and, potentially, viewpoints. The use of English language in conducting the study may have restricted the composition of the expert panel and, by extension, the study outputs. The size of Delphi panels can range widely. This written report included 44 individuals, which is within the 10 to 50 generally recommended for proficient panels¹²². Members were from 22 countries across the six WHO regions. Nosotros note that 25% of them worked in a country unlike from their country of origin and speculate that their cess of consensus points may have benefitted from their various backgrounds. Nonetheless, this also meant that in the case of Africa, with its disproportionate burden of HIV, ii of the six African members no longer worked on the continent. Thus, it is not articulate to what extent they considered the African context in their cess of consensus points. That the limerick of the panel reflected activities spanning inquiry, service provision, community-based care, policy, and advocacy provided the project with expertise and knowledge regarding the priorities of diverse stakeholder groups.

An advantage of using scoping reviews for the 3 domains is that expert panel members could describe on their knowledge and experience to focus on issues that pertain to improving the well-being of PLHIV but may not yet be extensively documented in the peer-reviewed or gray literature. A further strength of the study was the collection of open-ended (text-based) comments from respondents who agreed with statements (e.1000., for farther input and suggested edits), equally well equally from respondents who disagreed (e.k., to understand their rationale and suggested changes). This elicitation and incorporation of feedback from respondents across all iii survey rounds (with high response rates, i.eastward., R1, R2 = 86%; R3 = 91%) and the online meeting were likely critical to the consistent increase in levels of agreement.

Finally, the worldwide relevance of the expert console'southward consensus is suggested by the fact that the consensus statement had been endorsed by 67 organizations (Box 2) at the time this commodity went to press.

Decision

Prevention and treatment of HIV infection including admission to Fine art remain a major public wellness and homo rights challenge that requires urgent, sustained attention. This consensus statement addresses the concurrent role of health systems in advancing the long-term well-being of PLHIV. Multimorbidity, HRQoL, and stigma and discrimination continue to be major issues for PLHIV, including those who have achieved viral suppression and in particular those from marginalized populations.

The consensus statement was prepared by a large multidisciplinary panel of experts representing the interests of a diverse range of stakeholders including HIV community members. Its purpose was to facilitate consensus on major health-related issues affecting PLHIV to exist addressed from a patient-centered perspective, noting that many issues are not captured in current HIV monitoring processes and guidelines. While additional enquiry is needed, the brunt of creating new, simple, standardized indicators for insufficiently addressed bug will largely fall on international bodies such as WHO and UNAIDS, both of which have mechanisms for community consultation and date. This process volition require a stiff commitment from all Member States, which must report on the indicators and implement policies to enhance health organisation functioning. We encourage these organizations and national health system monitoring bodies to go on to take on this task, to report at regular intervals, and to meaningfully involve PLHIV, even when boosted costs are involved. PLHIV and civil gild organizations should also play a role in reporting ways in which governments are not meeting their obligations. Ultimately, a concerted endeavour by all stakeholders is required to ensure the long-term well-being of the millions of people effectually the world living with HIV and to end the HIV pandemic.

References

1. UNAIDS. Prevailing against pandemics past putting people at the centre: Globe AIDS Solar day Report 2020. https://www.unaids.org/en/resource/documents/2020/prevailing-against-pandemics (2020).

2. Collaboration Antiretroviral Therapy Cohort. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 4, e349–e356 (2017).

3. Engelhard, Due east. A. N. et al. Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases. AIDS 32, 103–112 (2018).

   PubMed  Article  PubMed Central  Google Scholar

4. Langebeek, Due north. et al. Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals. AIDS 31, 1471–1481 (2017). This cohort-control study finds an association between positive HIV status and worse physical and mental HRQoL, despite viral suppression .

5. Miners, A. et al. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the full general population. Lancet HIV 1, e32–e40 (2014). This study documents lower HRQoL among PLHIV than the general public, regardless of viral suppression or use of antiretroviral therapy .

   PubMed  Article  PubMed Cardinal  Google Scholar

6. Seth, P. et al. Psychosocial performance and depressive symptoms among HIV-positive persons receiving care and treatment in Kenya, Namibia, and Tanzania. Prev. Sci. 15, 318–328 (2014).

   PubMed  PubMed Central  Article  Google Scholar

7. Degroote, Southward., Vogelaers, D. & Vandijck, D. M. What determines health-related quality of life among people living with HIV: an updated review of the literature. Curvation. Public Heal. 72, i–x (2014). This review records and evaluates common factors affecting HRQoL amongst PLHIV .

   Commodity  Google Scholar

8. Bristowe, K. et al. Towards person-centred intendance for people living with HIV: what core outcomes thing, and how might we assess them? A cross-national multi-eye qualitative written report with key stakeholders. HIV Med. 20, 542–554 (2019).

   CAS  PubMed  PubMed Key  Google Scholar

9. Kyu, H. H. et al. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Brunt of Affliction 2013 Study. JAMA Pediatr. 170, 267–287 (2016).

   PubMed  Article  PubMed Central  Google Scholar

10. Olson, B. et al. Depressive symptoms, physical symptoms, and health-related quality of life amidst older adults with HIV. Qual. Life Res. 28, 3313–3322 (2019). This report finds that the prevalence of concrete and mental wellness problems predicts HRQoL among PLHIV aged 50 and over, regardless of viral suppression or time since diagnosis .

    PubMed  PubMed Central  Article  Google Scholar

11. Catalan, J., Tuffrey, V., Ridge, D. & Rosenfeld, D. What influences quality of life in older people living with HIV? AIDS Res. Ther. 14, 22 (2017).

    PubMed  PubMed Central  Article  Google Scholar

12. Nguyen, A. L., McNeil, C. J., Han, South. D. & Rhodes, S. D. Take chances and protective factors for health-related quality of life among persons aging with HIV. AIDS Care 30, 518–522 (2018).

    PubMed  Article  PubMed Primal  Google Scholar

13. Drewes, J., Ebert, J., Langer, P. C., Kleiber, D. & Gusy, B. Social inequalities in health-related quality of life among people crumbling with HIV/AIDS: the role of comorbidities and disease severity. Qual. Life Res. 29, 1549–1557 (2020).

    PubMed  PubMed Primal  Article  Google Scholar

14. Ghiasvand, H. et al. Social and demographical determinants of quality of life in people who live with HIV/AIDS infection: evidence from a meta-analysis. Biodemogr. Soc. Biol. 65, 57–72 (2019).

    Article  Google Scholar

15. Andersson, G. Z. et al. Stigma reduction interventions in people living with HIV to improve wellness-related quality of life. Lancet HIV 7, e129–e140 (2020). This review reports stigma processes that disrupt HRQoL and identifies noesis gaps and recommendations in the development of anti-stigma interventions for HIV stigma .

    PubMed  Article  PubMed Central  Google Scholar

16. Lowther, K., Selman, Fifty., Harding, R. & Higginson, I. J. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (Art): a systematic review. Int. J. Nurs. Stud. 51, 1171–1189 (2014). This study documents that anxiety and depression are more mutual among PLHIV than in the general population or other chronic conditions such as cancer and diabetes .

    PubMed  Article  PubMed Central  Google Scholar

17. Nyblade, L., Mingkwan, P. & Stockton, M. A. Stigma reduction: an essential ingredient to ending AIDS by 2030. Lancet HIV 8, e106–e113 (2021).

    PubMed  Article  PubMed Central  Google Scholar

18. Giusti, A. et al. The empirical evidence underpinning the concept and practise of person-centred care for serious illness: a systematic review. BMJ Glob. Heal. 5, 3330 (2020).

    Google Scholar

19. WHO. Global Health Sector Strategy on HIV 2016–2021. https://apps.who.int/iris/bitstream/handle/10665/246178/WHO-HIV-2016.05-eng.pdf (2016).

20. UNAIDS. 90-xc-90 an Ambitious Treatment Target to Help Terminate the AIDS Epidemic. https://world wide web.unaids.org/sites/default/files/media_asset/90-xc-90_en.pdf (2014).

21. United Nations. International Covenant on Economic, Social and Cultural Rights. https://www.ohchr.org/en/professionalinterest/pages/cescr.aspx (1967).

22. Earth Wellness Organization. Global Health Sector Strategy on HIV, 2016–2021: toward Catastrophe AIDS. https://apps.who.int/iris/bitstream/handle/10665/246178/WHO-HIV-2016.05-eng.pdf (2016).

23. UNAIDS. Terminate Inequalities. End AIDS. Global AIDS Strategy 2021–2026. http://www.infocop.es/pdf/global-AIDS.pdf (2021).

24. Institute for Global Health University College London. Positive Voices: The national survey of people living with HIV. https://www.ucl.ac.uk/global-health/enquiry/z-inquiry/positive-voices-national-survey-people-living-hiv (2020).

25. HIV Outcomes. HIV Outcomes Across Viral Suppression: Recommendations. https://www.unaids.org/en/resources/documents/2020/prevailing-against-pandemics (2017).

26. Giusti, A. et al. The empirical bear witness underpinning the concept and exercise of person-centred care for serious illness: a systematic review. BMJ Glob. Heal. v, 3330 (2020).

    Google Scholar

27. Adler, M. & Ziglio, Eastward. Gazing Into the Oracle: the Delphi Method and Its Awarding to Social Policy and Public Wellness. (Jessica Kingsley Publishers, 1996).

28. Rubino, F. et al. Joint international consensus statement for ending stigma of obesity. Nat. Med. 26, 485–497 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar

29. Cantrill, J. A., Sibbald, B. & Buetow, S. The Delphi and nominal group techniques in wellness services enquiry. Int. J. Pharm. Pract. 4, 67–74 (1996).

    Article  Google Scholar

30. Sabin, C. A. & Reiss, P. Epidemiology of ageing with HIV: what tin can nosotros acquire from cohorts? AIDS 31, S121–S128 (2017). This article reviews some of the changes seen in the prevalence of comorbidities among cohorts of people living with HIV every bit they have aged, but likewise cautions about the possible over-interpretation of some changes in relation to the attribution of these to HIV itself or its treatment .

31. Smit, Chiliad. et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect. Dis. 15, 810–818 (2015).

    PubMed  PubMed Central  Article  Google Scholar

32. Saloner, R. et al. Effects of comorbidity burden and historic period on brain integrity in HIV. AIDS 33, 1175–1185 (2019).

    PubMed  Article  PubMed Key  Google Scholar

33. Platt, L. et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect. Dis. xvi, 797–808 (2016).

    PubMed  Article  PubMed Central  Google Scholar

34. Earth Health Organization. Global Hepatitis Report. https://www.who.int/publications/i/detail/global-hepatitis-report-2017 (2017).

35. Globe Health Organisation. Global Tuberculosis Report. https://world wide web.who.int/publications/i/particular/9789240013131 (2020).

36. Michaud, J. Yard., Zhang, T., Shireman, T. I., Lee, Y. & Wilson, I. B. Gamble of cervical, oropharyngeal, and anal cancers in HIV-infected and HIV-uninfected medicaid beneficiaries. Cancer Epidemiol. Biomark. Prev. 29, 1447–1457 (2020).

    Article  Google Scholar

37. Boyd, Chiliad. A. et al. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: a prospective analysis of the D:A:D observational study. PLoS Med. xiv, e1002424 (2017).

    PubMed  PubMed Central  Article  Google Scholar

38. Edmiston, Due north., Petoumenos, K. & Smith, D. J. Multimorbidity, not human being immunodeficiency virus (HIV) markers predicts unplanned access among people with HIV in regional New South Wales. Intern. Med. J. 48, 706–713 (2018).

    PubMed  Article  PubMed Central  Google Scholar

39. Cammarota, Due south., Citarella, A., Manzoli, L., Flacco, M. E. & Parruti, G. Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: Real-world data from Abruzzo region. Clin. Outcomes Res. 10, 389–398 (2018).

    Article  Google Scholar

40. Guaraldi, G. et al. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65-74 years and more than 75 years. BMC Geriatr. 18, 1–10 (2018).

41. Guaraldi, 1000. et al. Late presentation increases run a risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact written report. AIDS Res. Ther. fourteen, 8 (2017).

    PubMed  PubMed Cardinal  Article  Google Scholar

42. Wong, C. et al. Multimorbidity amongst persons living with human immunodeficiency virus in the United states of america. Clin. Infect. Dis. 66, 1230–1238 (2018).

    PubMed  Article  PubMed Central  Google Scholar

43. Rajasuriar, R. et al. Persistent immune activation in chronic HIV infection: do any interventions work? AIDS 27, 1199–1208 (2013).

    PubMed  Article  PubMed Central  Google Scholar

44. Zicari, South. et al. Immune activation, inflammation, and not-AIDS co-morbidities in HIV-infected patients nether long-term ART. Viruses 11, 200 (2019).

45. Bromberg, D. J., Mayer, M. H. & Altice, F. L. Identifying and managing infectious disease syndemics in patients with HIV. Curr. Opin. HIV AIDS 15, 232–242 (2020).

    PubMed  PubMed Central  Google Scholar

46. Muiruri, C. et al. Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: a narrative review of the literature. Prog. Cardiovasc. Dis. 63, 142–148 (2020).

    PubMed  PubMed Key  Article  Google Scholar

47. Bristowe, K. et al. Recommendations to reduce inequalities for LGBT people facing avant-garde illness: ACCESSCare national qualitative interview study. Palliat. Med. 32, 23–35 (2018).

    PubMed  Article  PubMed Primal  Google Scholar

48. Womack, J. A. & Justice, A. C. The OATH syndemic: opioids and other substances, aging, alcohol, tobacco, and HIV. Curr. Opin. HIV AIDS 15, 218–225 (2020).

    PubMed  PubMed Central  Google Scholar

49. The Global Fund. Technical Cursory HIV, Man Rights, and Gender Equality. https://world wide web.theglobalfund.org/media/6348/core_hivhumanrightsgenderequality_technicalbrief_en.pdf?u=637166001220000000 (2019).

50. Bhardwaj, A. & Kohrt, B. A. Syndemics of HIV with mental disease and other noncommunicable diseases: a research calendar to accost the gap between syndemic theory and electric current research do. Curr. Opin. HIV AIDS 15, 226–231 (2020).

    PubMed  PubMed Central  Google Scholar

51. García-Goñi, G., Stoyanova, A. P. & Nuño-Solinís, R. Mental illness inequalities past multimorbidity, employ of health resources and socio-economic condition in an aging guild. Int. J. Environ. Res. Public Health 18, 458 (2021).

    PubMed Central  Article  Google Scholar

52. Bekker, L.-Thousand. et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet 392, 312–358 (2018).

    PubMed  PubMed Cardinal  Commodity  Google Scholar

53. O'Brien, Thou. Thousand. et al. Research priorities for rehabilitation and crumbling with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC). AIDS Res. Ther. 17, 21 (2020).

    PubMed  PubMed Central  Commodity  Google Scholar

54. Sabin, C. A. et al. Associations between widespread pain and slumber quality in people with HIV. J. Acquir. Immune Defic. Syndr. 85, 106–112 (2020).

    CAS  PubMed  Commodity  PubMed Primal  Google Scholar

55. Guaraldi, G. & Milic, J. The coaction between frailty and intrinsic capacity in crumbling and HIV infection. AIDS Res. Hum. Retroviruses 35, 1013–1022 (2019).

    PubMed  Commodity  PubMed Cardinal  Google Scholar

56. World Wellness Arrangement. International Classification of Performance, Disability and Health. https://www.who.int/standards/classifications/international-classification-of-performance-inability-and-wellness (2001).

57. International Health Conference. Constitution of the World Health Organization. https://www.who.int/governance/eb/who_constitution_en.pdf (2006).

58. United nations Committee on Economic, S. & C. R. General comment no. 14 (2000) The Right to the Highest Accessible Standard of Health. https://www.refworld.org/pdfid/4538838d0.pdf (United Nations, 2000).

59. Kall, M., Marcellin, F., Harding, R., Lazarus, J. 5. & Carrieri, P. Patient-reported outcomes to enhance person-centred HIV care. Lancet HIV 7, e59–e68 (2020). This review details the use of patient-reported outcomes in HIV clinical care and identifies priorities for their awarding to personalise intendance and address stigma .

60. Drewes, J., Gusy, B. & Von Rüden, U. More than 20 years of enquiry into the quality of life of people with HIV and AIDS - a descriptive review of study characteristics and methodological approaches of published empirical studies. J. Int. Assoc. Provid. AIDS Care 12, 18–22 (2013). This review records the use of more than than 40 quality of life tools, and their methodologies, that were used in studies assessing the QoL of PLHIV between 1989 and 2013 .

    PubMed  Article  Google Scholar

61. Aden, B., Nosyk, B., Wittenberg, Eastward. & Schackman, B. R. Wellness-related quality of life in HIV-infected and at-risk women: the impact of illicit drug use and hepatitis C on a community preference weighted measure. Med. Decis. Mak. 34, 800–808 (2014).

    Article  Google Scholar

62. Préau, Thousand. et al. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS 21, S19–S27 (2007).

    PubMed  Article  Google Scholar

63. Degroote, S., Vogelaers, D. & Vandijck, D. Grand. What determines health-related quality of life among people living with HIV: an updated review of the literature. Archive. Public Health https://doi.org/ten.1186/2049-3258-72-40 (2014).

64. Ryu, E., Westward, S. Thou. & Sousa, One thousand. H. Arbitration and moderation: testing relationships between symptom status, functional health, and quality of life in HIV patients. Multivar. Behav. Res. 44, 213–232 (2009).

    Article  Google Scholar

65. Nguyen, A. L., McNeil, C. J., Knuckles Han, Southward. & Rhodes, Southward. D. Risk and protective factors for health-related quality of life among persons crumbling with HIV HHS public admission. AIDS Intendance thirty, 518–522 (2018).

    PubMed  Article  PubMed Central  Google Scholar

66. Sabin, C. A. et al. Hurting in people living with HIV and its clan with healthcare resource use, well being and functional status. AIDS 32, 2697–2706 (2018).

    PubMed  Article  PubMed Central  Google Scholar

67. Anis, A. H. et al. Quality of life of patients with advanced HIV/AIDS: Measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J. Acquir. Immune Defic. Syndr. 51, 631–639 (2009).

    PubMed  Commodity  Google Scholar

68. Pimentel, G. S. et al. Quality of life in individuals initiating antiretroviral therapy: a accomplice study. Rev. Saude Publica 54, 146 (2020).

    PubMed  PubMed Central  Article  Google Scholar

69. Emuren, L. et al. Lower health-related quality of life predicts all-cause hospitalization amidst HIV-infected individuals. Health Qual. Life Outcomes xvi, 107 (2018).

    PubMed  PubMed Cardinal  Article  Google Scholar

70. De Boer-van Der Kolk, I. M. et al. Health-related quality of life and survival amongst HIV-infected patients receiving highly agile antiretroviral therapy: a report of patients in the AIDS therapy Evaluation in the Netherlands (ATHENA) cohort. Clin. Infect. Dis. 50, 255–263 (2010).

    PubMed  Article  PubMed Central  Google Scholar

71. Mathews, West. C. & May, Due south. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults nether intendance. Health Qual. Life Outcomes 5, 5 (2007).

    PubMed  PubMed Central  Article  Google Scholar

72. Abboah-Offei, One thousand. et al. How can nosotros achieve person-centred care for people living with HIV/AIDS? A qualitative interview study with healthcare professionals and patients in Ghana. AIDS Care https://doi.org/10.1080/09540121.2019.1698708 (2019).

73. Lowther, K. et al. Agile ingredients of a person-centred intervention for people on HIV treatment: analysis of mixed methods trial information. BMC Infect. Dis. eighteen, 27 (2018).

    PubMed  PubMed Primal  Article  Google Scholar

74. Selman, Fifty. Eastward. et al. Quality of life among patients receiving palliative care in South Africa and Uganda: a multi-centred report. Health Qual. Life Outcomes 9, 1–14 (2011).

75. Justice, A. C., Chang, C. H., Rabeneck, L. & Zackin, R. Clinical importance of provider-reported HIV symptoms compared with patient-written report. Med. Care 39, 397–408 (2001).

    CAS  PubMed  Commodity  PubMed Central  Google Scholar

76. Harding, R. & Molloy, T. Positive futures? The impact of HIV infection on achieving health, wealth and futurity planning. AIDS Care 20, 565–570 (2008).

    PubMed  Article  PubMed Central  Google Scholar

77. Herrmann, S. et al. HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection. Wellness Qual. Life Outcomes eleven, ane–13 (2013).

78. Garrido-Hernansaiz, H., Heylen, E., Bharat, S., Ramakrishna, J. & Ekstrand, Yard. Fifty. Stigmas, symptom severity and perceived social back up predict quality of life for PLHIV in urban Indian context. Wellness Qual. Life Outcomes 14, 1–ix (2016).

79. Duracinsky, 1000. et al. Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease. J. Acquir. Immune Defic. Syndr. 59, 506–515 (2012).

    PubMed  Article  PubMed Primal  Google Scholar

80. UNAIDS. Global Partnership for Action to Eliminate All Forms of HIV-related Stigma and Bigotry. (2018).

81. Mak, W. Westward. S., Mo, P. K. H., Ma, G. Y. K. & Lam, M. Y. Y. Meta-analysis and systematic review of studies on the effectiveness of HIV stigma reduction programs. Soc. Sci. Med. 188, 30–40 (2017).

    PubMed  Article  PubMed Key  Google Scholar

82. Gesesew, H. A. et al. Significant clan betwixt perceived HIV related stigma and late presentation for HIV/AIDS care in low and heart-income countries: a systematic review and meta-analysis. PLoS ONE 12, e0173928 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar

83. Yuvaraj, A. et al. HIV and stigma in the healthcare setting. Oral. Dis. 26, 103–111 (2020).

    PubMed  Article  PubMed Fundamental  Google Scholar

84. Stockton, M. A., Giger, K. & Nyblade, L. A scoping review of the role of HIV-related stigma and discrimination in noncommunicable disease care. PLoS Ane 13, e0199602 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar

85. Grimsrud, A. et al. Reimagining HIV service commitment: the role of differentiated intendance from prevention to suppression. J. Int. AIDS Soc. nineteen,21484 (2016).

86. Negin, J. et al. Health expenditure and catastrophic spending among older adults living with HIV. Glob. Public Heal. 12, 1282–1296 (2017).

    Commodity  Google Scholar

87. Hatzenbuehler, Thou. L., Phelan, J. C. & Link, B. G. Stigma every bit a fundamental cause of population health inequalities. Am. J. Public Heal. 103, 813–821 (2013).

    Article  Google Scholar

88. Jackson-Best, F. & Edwards, N. Stigma and intersectionality: a systematic review of systematic reviews across HIV/AIDS, mental illness, and physical disability. BMC Public Health xviii, 919 (2018).

    PubMed  PubMed Central  Article  Google Scholar

89. Committee on the Science of Changing Behavioral Wellness Social Norms; Board on Behavioral, C. Approaches to Reducing Stigma. in Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change (National Academies Printing, 2016).

90. Feyissa, G. T., Lockwood, C., Woldie, Thousand. & Munn, Z. Reducing HIV-related stigma and discrimination in healthcare settings: a systematic review of guidelines, tools, standards of do, best practices, consensus statements and systematic reviews. J. Multidiscip. Heal. 11, 405–416 (2018).

    Commodity  Google Scholar

91. Hutchinson, J., Sutcliffe, L. J., Williams, A. J. & Estcourt, C. S. Developing new models of shared primary and specialist HIV intendance in the UK: a survey of current exercise. Int. J. STD AIDS 27, 617–624 (2016).

    PubMed  Article  PubMed Central  Google Scholar

92. Guaraldi, One thousand. et al. Homo Immunodeficiency Virus (HIV) care models during the Coronavirus Affliction 2019 (COVID-19) Era. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa1864 (2020).

93. Friedland, B. A. et al. The People Living with HIV Stigma Index two.0: generating critical evidence for alter worldwide. AIDS 34, S5–S18 (2020). This commodity describes the process of updating and validating the existing Stigma Index tool to take business relationship of the current context of HIV treatment and care, thereby increasing its applicability and relevance .

    PubMed  Article  PubMed Central  Google Scholar

94. Berger, B. E., Ferrans, C. Due east. & Lashley, F. R. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma calibration. Res. Nurs. Heal. 24, 518–529 (2001).

    CAS  Article  Google Scholar

95. Wouters, E. et al. Measuring HIV- and TB-related stigma among wellness care workers in South Africa: a validation and reliability written report. Int. J. Tuberc. Lung Dis. 21, 19–25 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar

96. Alexandra Marshall, Due south., Brewington, K. M., Kathryn Allison, Grand., Haynes, T. F. & Zaller, Due north. D. Measuring HIV-related stigma among healthcare providers: a systematic review. AIDS Care 29, 1337–1345 (2017).

    CAS  PubMed  Article  PubMed Primal  Google Scholar

97. Wagner, A. C., Hart, T. A., McShane, K. E., Margolese, S. & Girard, T. A. Wellness intendance provider attitudes and behavior about people living with HIV: Initial validation of the Health Care Provider HIV/AIDS Stigma Scale (HPASS). AIDS Behav. 18, 2397–2408 (2014).

    PubMed  Commodity  PubMed Central  Google Scholar

98. Uys, L. R. et al. The development and validation of the HIV/AIDS Stigma Musical instrument-Nurse (HASI-N). AIDS Care 21, 150–159 (2009).

    PubMed  PubMed Primal  Article  Google Scholar

99. UNAIDS. Guidance Note: Reduction of HIV-Related Stigma and Discrimination. https://www.unaids.org/sites/default/files/media_asset/2014unaidsguidancenote_stigma_en.pdf (2014).

100. UNAIDS. Global Partnership for Action to Eliminate All Forms of HIV-Related Stigma and Bigotry. https://www.unaids.org/sites/default/files/media_asset/global-partnership-hiv-stigma-discrimination_en.pdf (2018).

101. Li, L., Guan, J., Liang, L. J., Lin, C. & Wu, Z. Popular opinion leader intervention for HIV stigma reduction in health intendance settings. AIDS Educ. Prev. 25, 327–335 (2013).

     CAS  PubMed  PubMed Central  Article  Google Scholar

102. Pantelic, Thousand., Steinert, J. I., Park, J., Mellors, Southward. & Murau, F. 'Management of a spoiled identity': systematic review of interventions to address self-stigma among people living with and affected past HIV. BMJ Glob. Heal. four, e001285 (2019).

     Article  Google Scholar

103. Stangl, A. L., Lloyd, J. M., Brady, L. M., Holland, C. E. & Baral, S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J. Int. AIDS Soc. 16, 18734 (2013).

     PubMed  PubMed Central  Article  Google Scholar

104. United Nations Full general Associates. Transforming Our World: the 2030 Agenda for Sustainable Development. https://sdgs.un.org/2030agenda (2015).

105. United nations. Political Declaration of the High-level Coming together on Universal Wellness Coverage "Universal health coverage: moving together to build a healthier world". https://www.un.org/pga/73/wp-content/uploads/sites/53/2019/07/FINAL-draft-UHC-Political-Announcement.pdf (2019).

106. Earth Wellness Organization. Framework on Integrated, People-centred Health Services. https://www.unaids.org/en/resource/documents/2020/prevailing-against-pandemics (2016).

107. HIV Policy Lab. 2020 Global HIV Policy Report: Policy Barriers to HIV Progress. https://world wide web.unaids.org/en/resource/documents/2020/prevailing-against-pandemics (2020).

108. UNAIDS. Fast-Track and human rights—Advancing homo rights in efforts to accelerate the response to HIV. https://www.unaids.org/en/resources/documents/2020/prevailing-against-pandemics (2017).

109. UNAIDS. The Greater Involvement of People Living with HIV (GIPA). https://data.unaids.org/pub/briefingnote/2007/jc1299_policy_brief_gipa.pdf (2007).

110. UNAIDS Programme Coordinating Lath. The Role of Communities in Catastrophe AIDS by 2030. https://www.unaids.org/en/resources/documents/2016/UNAIDS_PCB38_16.xiv (2016).

111. United Nations General Assembly. Political Declaration on HIV and AIDS: Ending Inequalities and Getting on Track to Cease AIDS by 2030. https://www.unaids.org/en/resources/documents/2021/2021_political-declaration-on-hiv-and-aids (2021).

112. Brown, D. A. et al. Evaluation of the psychometric properties of the HIV Inability Questionnaire amidst adults living with HIV in the Britain: a cross-sectional self-report measurement study. PLoS Ane 14, e0213222 (2019).

113. den Daas, C. et al. Health-related quality of life amongst adult HIV positive patients: assessing comprehensive themes and interrelated associations. Qual. Life Res. 28, 2685–2694 (2019). This written report validates a tool to comprehensively assess HRQoL amid PLHIV past drawing from comonly-used tools, finding stigma, social back up and cocky-esteem most strongly associated with HRQoL .

     Article  Google Scholar

114. Downing, J. et al. Outcomes 'out of Africa: the choice and implementation of consequence measures for palliative care in Africa. BMC Palliat. Care 11, one–7 (2012).

     PubMed  PubMed Central  Article  Google Scholar

115. Harding, R., Gwyther, L., Mwangi-Powell, F., Powell, R. A. & Dinat, N. How can nosotros improve palliative intendance patient outcomes in low- and centre-income countries? Successful outcomes research in sub-saharan Africa. J. Hurting. Symptom Manag. twoscore, 23–26 (2010).

     Commodity  Google Scholar

116. Blum, D. et al. Cocky-report measurement of pain and symptoms in palliative care patients: a comparing of verbal, visual and hand scoring methods in Sub-Saharan Africa. Health Qual. Life Outcomes 12, one–ix (2014).

117. Harding, R. et al. Design and evaluation of a novel mobile phone application to improve palliative home-care in resource-limited settings. J. Pain Symptom Manage. https://doi.org/10.1016/j.jpainsymman.2020.09.045 (2020).

118. Ehrenkranz, P., Grimsrud, A. & Rabkin, M. Differentiated service delivery: navigating the path to scale. Curr. Opin. HIV AIDS 14, 60–65 (2019).

     PubMed  Commodity  PubMed Central  Google Scholar

119. Safreed-Harmon, K. et al. Power to monitor national responses to the HIV Epidemic "beyond viral suppression": findings from half dozen European countries. Front. Public Heal. 8, 36 (2020).

     ADS  Article  Google Scholar

120. Safreed-Harmon, K. et al. Reorienting health systems to treat people with HIV beyond viral suppression. Lancet HIV half dozen, e869–e877 (2019). This review describes emerging long-term care challenges in the era of effective HIV handling and identifies means in which health systems can meet these challenges and promote healthy aging for people living with HIV .

     PubMed  Commodity  PubMed Cardinal  Google Scholar

121. Grime, G. M. & Wright, G. Delphi Method. In Wiley StatsRef: Statistics Reference Online 1–6 (John Wiley & Sons, Ltd, 2016).

122. Turoff, K. The Policy Delphi. In The Delphi Method: Techniques and Applications.https://spider web.njit.edu/~turoff/pubs/delphibook/index.html (2002).

123. Cooper, V., Clatworthy, J., Harding, R. & Whetham, J. Measuring quality of life among people living with HIV: a systematic review of reviews. Health Qual. Life Outcomes 15, 220 (2017).

     PubMed  PubMed Central  Article  Google Scholar

124. Karimi, M., & Brazier, J. Health, health-related quality of life, and quality of life: what is the difference?. Pharmacoeconomics 34, 645–649 (2016).

     PubMed  Article  PubMed Central  Google Scholar

125. Globe Health System. Everybody'southward Business organization: Strengthening Health Systems to Improve Health Outcomes. https://world wide web.who.int/healthsystems/strategy/everybodys_business.pdf (2008).

126. World Health Organization. WHO Global Strategy on People-centred and Integrated Health Services: Interim Report. https://apps.who.int/iris/handle/10665/155002 (2015).

127. Herek, G. M. Confronting sexual stigma and prejudice: theory and practise. J. Soc. Bug 63, 905–925 (2007).

     Commodity  Google Scholar

128. Turan, J. M. et al. Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Med. 17, 7 (2019).

     PubMed  PubMed Fundamental  Article  Google Scholar

129. World Wellness Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. https://world wide web.euro.who.int/en/publications/abstracts/consolidated-guidelines-on-hiv-prevention,-diagnosis,-treatment-and-care-for-key-populations-2014 (2014).

130. Adler, North. Eastward. & Page, A. Due east. K. Cancer Intendance for the Whole Patient: Meeting Psychosocial Health Needs. Cancer Intendance for the Whole Patient: Coming together Psychosocial Health Needs. (National Academies Press, 2008).

Download references

Acknowledgements

The authors acknowledge the editorial and analytical contributions of Trenton M. White, support implementing the Delphi methodology by Ansley Hobbs, and editorial review by Beatriz Grinsztejn.

Writer information

Affiliations

1. Barcelona Institute for Global Wellness (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain

   Jeffrey V. Lazarus, Kelly Safreed-Harmon & Denise Naniche

2. University of Malaya, Kuala Lumpur, Malaysia

   Adeeba Kamarulzaman & Reena Rajasuriar

3. International AIDS Club (IAS), Geneva, Switzerland

   Adeeba Kamarulzaman

4. Homerton Academy Hospital NHS Foundation Trust, London, Great britain

   Jane Anderson

5. Portuguese National Parliament, Lisbon, Portugal

   Ricardo Baptista Leite

6. Medizinische Hochschule Hannover (MHH), Hannover, Frg

   Georg Behrens

7. The Desmond Tutu HIV Centre, Greatcoat Town, South Africa

   Linda-Gail Bekker

8. Royal Gratuitous London NHS Trust and University Higher London, London, Great britain

   Sanjay Bhagani

9. Chelsea and Westminster NHS Foundation Trust, London, United Kingdom

   Darren Brownish & Anton Pozniak

10. Middle for Social Impact, Academy of New South Wales, Sydney, Australia

    Graham Brown

11. Span HIV, San Francisco Department of Public Wellness, San Francisco, United States

    Susan Buchbinder

12. Center for Research in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Republic of peru

    Carlos Caceres

13. Fundación Huésped, Buenos Aires, Argentine republic

    Pedro E. Cahn

14. Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de 50'Data Médicale, ISSPAM, Marseilles, France

    Patrizia Carrieri

15. Global Network of People Living with HIV (GNP+), Cape Town, South Africa

    Georgina Caswell

16. Purple College London, London, Great britain

    Graham S. Cooke & Tim Hallett

17. University of Milan, Milan, Italy

    Antonella d'Arminio Monforte

18. Positive Phonation, Athens, Greece

    Nikos Dedes

19. National Program on AIDS, Ministry of Health, Madrid, Spain

    Julia del Amo

20. HIV Legal Network, Toronto, Canada

    Richard Elliott

21. ICAP at Columbia University, New York City, Usa

    Wafaa M. El-Sadr

22. Castilian AIDS Interdisciplinary Lodge (SEISIDA), Madrid, Spain

    María José Fuster-Ruiz de Apodaca

23. Universidad Nacional de Educación a Distancia, Madrid, Spain

    María José Fuster-Ruiz de Apodaca

24. Modena HIV Metabolic Clinic, Università degli studi di Modena east Reggio Emilia, Modena, Italy

    Giovanni Guaraldi

25. King'southward College London, London, United Kingdom

    Richard Harding

26. Burnet Institute, Melbourne, Australia

    Margaret Hellard

27. Liverpool Schoolhouse of Tropical Medicine, Liverpool, U.k.

    Shabbar Jaffar

28. Public Wellness England, London, U.k.

    Meaghan Kall

29. McGill University Health Centre Research Institute, Montreal, Canada

    Marina Klein

30. Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Commonwealth of australia

    Sharon R. Lewin

31. Victorian Infectious Diseases Service, The Regal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

    Sharon R. Lewin

32. Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Commonwealth of australia

    Sharon R. Lewin

33. Fenway Health and Harvard Medical School, Boston, United States

    Ken Mayer

34. Infectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain

    Jose A. Pérez-Molina

35. ESA YOUTH 2030, Nairobi, Kenya

    Doreen Moraa

36. City University of New York Graduate School of Public Health and Wellness Policy, New York City, United States

    Denis Nash & Diana Romero

37. European Eye for Disease Control and Prevention, Solna, Sweden

    Teymur Noori

38. London School of Hygiene and Tropical Medicine, London, United kingdom

    Anton Pozniak

39. Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands

    Peter Reiss

40. American University of Beirut, Beirut, Lebanon

    Nesrine Rizk

41. University Infirmary Bonn, Bonn, Deutschland

    Jürgen Rockstroh

42. Academy College London, London, United Kingdom

    Caroline Sabin

43. Makerere University School of Public Health, Kampala, Republic of uganda

    David Serwadda

44. Central and North Due west London NHS Trust, London, United Kingdom

    Laura Waters

Contributions

J.V.L. and K.South.H. conceived of the consensus statement, which was chaired past J.V.L., A.K., N.D., and R.B.L. J.Five.L .and K.S.H. established the expert panel and steering commission, convened both groups in meetings and Delphi rounds, and drafted and revised the consensus points and manuscript. J.A., R.B.L., Grand.B., G.C., N.D., M.J.F., R.H., A.One thousand., and C.Southward. provided conceptual guidance towards drafting the consensus points. K.B. and A.M. led the multimorbidity scoping review; J.A. and G.C. led the stigma and discrimination scoping review; and R.H. and Yard.J.F. led the HRQoL scoping review. D.R. ensured the rigor of the Delphi methodology employed, oversaw its implementation, and contributed to data analysis. J.A., South.B., D.B., G.B., South.B., C.C., P.C., P.E.C., G.C., G.S.C., A.A.M., J.A., R.E., West.M.Due east., M.J.F., R.H., Chiliad.H., S.H., A.Thou., M.K., J.V.L., K.M., D.Due north., T.North., A.P., P.R., C.S., K.S., and D.S. contributed to editing the manuscript. All co-authors participated in the Delphi rounds and approved the terminal manuscript.

Corresponding author

Correspondence to Jeffrey Five. Lazarus.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Communications cheers Carl Dieffenbach, Marietjie de Villiers, Albert Wu and the other, bearding, reviewer(due south) for their contribution to the peer review of this work.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open up Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, accommodation, distribution and reproduction in any medium or format, every bit long as you lot give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and point if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is non included in the article's Creative Eatables license and your intended use is not permitted by statutory regulation or exceeds the permitted use, y'all will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Cite this commodity

Lazarus, J.V., Safreed-Harmon, 1000., Kamarulzaman, A. et al. Consensus statement on the role of health systems in advancing the long-term well-beingness of people living with HIV. Nat Commun 12, 4450 (2021). https://doi.org/10.1038/s41467-021-24673-westward

Download citation

• Received: 09 March 2021

• Accepted: 01 July 2021

• Published: sixteen July 2021

• DOI : https://doi.org/ten.1038/s41467-021-24673-w

Further reading

• Advancing the global public health calendar for NAFLD: a consensus statement

  • Jeffrey V. Lazarus
  • Henry E. Mark
  • Ming-Hua Zheng

  Nature Reviews Gastroenterology & Hepatology (2022)

Comments

Past submitting a comment you concord to bide by our Terms and Customs Guidelines. If yous find something abusive or that does not comply with our terms or guidelines please flag information technology as inappropriate.

weesebeciond88.blogspot.com

Source: https://www.nature.com/articles/s41467-021-24673-w

Share this post